121 related articles for article (PubMed ID: 11034252)
1. Insurance policies for prophylactic mastectomy: to cover or not to cover?
Piver MS
Ann Surg Oncol; 2000 Oct; 7(9):714. PubMed ID: 11034252
[No Abstract] [Full Text] [Related]
2. Current national health insurance coverage policies for breast and ovarian cancer prophylactic surgery.
Kuerer HM; Hwang ES; Anthony JP; Dudley RA; Crawford B; Aubry WM; Esserman LJ
Ann Surg Oncol; 2000 Jun; 7(5):325-32. PubMed ID: 10864338
[TBL] [Abstract][Full Text] [Related]
3. Summaries for patients. The cost-effectiveness of preventive strategies for breast and ovarian cancer for women with BRCA1 or BRCA2 mutations.
Ann Intern Med; 2006 Mar; 144(6):I40. PubMed ID: 16549849
[No Abstract] [Full Text] [Related]
4. Preventing breast, ovarian cancer in BRCA carriers: rational of prophylactic surgery and promises of surveillance.
Agnantis NJ; Paraskevaidis E; Roukos D
Ann Surg Oncol; 2004 Dec; 11(12):1030-4. PubMed ID: 15545500
[No Abstract] [Full Text] [Related]
5. Insurance policies for prophylactic surgery: to cover or not to cover?
Morrow M
Ann Surg Oncol; 2000 Jun; 7(5):321-2. PubMed ID: 10864336
[No Abstract] [Full Text] [Related]
6. Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation.
Anderson K; Jacobson JS; Heitjan DF; Zivin JG; Hershman D; Neugut AI; Grann VR
Ann Intern Med; 2006 Mar; 144(6):397-406. PubMed ID: 16549852
[TBL] [Abstract][Full Text] [Related]
7. Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients.
Grann VR; Panageas KS; Whang W; Antman KH; Neugut AI
J Clin Oncol; 1998 Mar; 16(3):979-85. PubMed ID: 9508180
[TBL] [Abstract][Full Text] [Related]
8. Re: Potential for bias in studies on efficacy of prophylactic surgery for BRCA1 and BRCA2 mutation carriers.
Foulkes WD
J Natl Cancer Inst; 2003 Sep; 95(17):1344; author reply 1344. PubMed ID: 12953090
[No Abstract] [Full Text] [Related]
9. Breast and ovarian cancer prone women and prophylactic surgery temptation.
Eisinger F; Julian-Reynier C; Stoppa-Lyonnet D; Vennin P; Lasset C; Noguès C; Sobol H
J Clin Oncol; 1998 Jul; 16(7):2573-5. PubMed ID: 9667284
[No Abstract] [Full Text] [Related]
10. Prophylactic cancer surgeries offer no guarantees, uncertain outcomes.
Holzman D
J Natl Cancer Inst; 1996 Oct; 88(20):1428-9. PubMed ID: 8841014
[No Abstract] [Full Text] [Related]
11. Cost-effectiveness of surveillance and prevention strategies in BRCA1/2 mutation carriers.
Yamauchi H; Nakagawa C; Kobayashi M; Kobayashi Y; Mano T; Nakamura S; Arai M
Breast Cancer; 2018 Mar; 25(2):141-150. PubMed ID: 29019095
[TBL] [Abstract][Full Text] [Related]
12. Variation in prophylactic surgery decisions.
Julian-Reynier C; Eisinger F; Evans G; Foulkes W; Sobol H
Lancet; 2000 Nov; 356(9242):1687. PubMed ID: 11089849
[No Abstract] [Full Text] [Related]
13. Changes in specialists' perspectives on cancer genetic testing, prophylactic surgery and insurance discrimination: then and now.
Matloff ET; Bonadies DC; Moyer A; Brierley KL
J Genet Couns; 2014 Apr; 23(2):164-71. PubMed ID: 23852268
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer.
Eisen A; Rebbeck TR; Wood WC; Weber BL
J Clin Oncol; 2000 May; 18(9):1980-95. PubMed ID: 10784640
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic bilateral salpingo-oophorectomy (PBSO) with or without prophylactic bilateral mastectomy (PBM) or no intervention in BRCA1 mutation carriers: a cost-effectiveness analysis.
Norum J; Hagen AI; Maehle L; Apold J; Burn J; Møller P
Eur J Cancer; 2008 May; 44(7):963-71. PubMed ID: 18362067
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic surgery recommended for BRCA1 carriers.
Cancer Discov; 2014 May; 4(5):OF1. PubMed ID: 24795013
[No Abstract] [Full Text] [Related]
17. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation.
Meijers-Heijboer EJ; Verhoog LC; Brekelmans CT; Seynaeve C; Tilanus-Linthorst MM; Wagner A; Dukel L; Devilee P; van den Ouweland AM; van Geel AN; Klijn JG
Lancet; 2000 Jun; 355(9220):2015-20. PubMed ID: 10885351
[TBL] [Abstract][Full Text] [Related]
18. Genetic counselling and prophylactic surgery in women from families with hereditary breast or ovarian cancer.
Lobb E; Meiser B
Lancet; 2004 Jun; 363(9424):1841-2. PubMed ID: 15183619
[No Abstract] [Full Text] [Related]
19. [Methods of surgical prevention of breast cancer and of ovarian cancer in BRCA mutation carriers].
Bit-Sava EM; Belogurova MB; Imianitov EN; Balandov SG; Korniushin OV; Borisov MK
Vopr Onkol; 2013; 59(2):5-11. PubMed ID: 23814843
[No Abstract] [Full Text] [Related]
20. Insurance adjudication favoring prophylactic surgery in hereditary breast-ovarian cancer syndrome.
Lynch HT; Severin MJ; Mooney MJ; Lynch J
Gynecol Oncol; 1995 Apr; 57(1):23-6. PubMed ID: 7705697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
